Two research teams at Leiden University have secured over €1 million in funding through the NACTAR programme (Dutch Research Agenda) to explore innovative solutions to antimicrobial resistance (AMR).
Led by Prof. Gilles van Wezel, the first project focuses on unlocking hidden antibiotics from soil bacteria using advanced genome-editing tools. The second, led by Dr. Karina Xavier in collaboration with Wageningen University, investigates how gut microbes can be used to prevent infections by outcompeting harmful bacteria.
Both projects reflect the interdisciplinary strength of the Leiden Bio Science Park and aim to contribute to safer, more effective alternatives to traditional antibiotics.
“These projects show how our research ecosystem is driving solutions to critical global challenges,” said an LBSP spokesperson.
Read more on the Leiden University website.
Leiden, 26 November 2025 – INFECTA, a Dutch clinical research organization specializing in infectious diseases, has signed a cooperation agreement with AHAM Vastgoed for the...
With construction in full swing, the new University Sports Centre (USC) is set to open its doors on December 1, 2025. The first visitors will be welcomed in February 2026,...
The Dutch Research Council (NWO) is investing €197 million in 11 large-scale research infrastructure projects that benefit both science and society. Leiden University and Leiden...